Increases in luteinizing hormone are associated with declines in cognitive performance

Molecular and Cellular Endocrinology

Volumn 269, Issue 1-2 SPEC. ISS., 2007, Pages 107-111

  Casadesus, Gemma ^a   Milliken, Erin L ^a   Webber, Kate M ^b   Bowen, Richard L ^c   Lei, Zhenmin ^d   Rao, C V ^d   Perry, George ^b,e   Keri, Ruth A ^a   Smith, Mark A ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Voyager Pharmaceutical Corporation   (United States)

^d University of Louisville School of Medicine   (United States)

^e University of San Antonio   (United States)

Author keywords

Alzheimer disease; Cognition; Estrogen; Gonadotropins; Hippocampus; Hormone replacement therapy; Luteinizing hormone; Menopause

Indexed keywords

LUTEINIZING HORMONE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HORMONE RELEASE; MAZE TEST; MENOPAUSE; MENTAL DETERIORATION; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; COGNITION; COGNITION DISORDERS; FEMALE; LUTEINIZING HORMONE; LUTEINIZING HORMONE, BETA SUBUNIT; MALE; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; RECEPTORS, LH;

EID: 33947593994     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.06.013     Document Type: Article

References (47)

1. Banasr M., Hery M., Brezun J.M., and Daszuta A. Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus. Eur. J. Neurosci. 14 (2001) 1417-1424
2. Birge S.J., McEwen B.S., and Wise P.M. Effects of estrogen deficiency on brain function. Implications for the treatment of postmenopausal women. Postgrad. Med. Spec. No (2001) 11-16
3. Bowen R.L., Isley J.P., and Atkinson R.L. An association of elevated serum gonadotropin concentrations and Alzheimer disease?. J. Neuroendocrinol. 12 (2000) 351-354
4. Bowen R.L., Verdile G., Liu T., Parlow A.F., Perry G., Smith M.A., Martins R.N., and Atwood C.S. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J. Biol. Chem. 279 (2004) 20539-20545
5. Breitner J.C., Silverman J.M., Mohs R.C., and Davis K.L. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology 38 (1988) 207-212
6. Casadesus G., Zhu X., Atwood C.S., Webber K.M., Perry G., Bowen R.L., and Smith M.A. Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 281-285
7. Casadesus G., Webber K.M., Atwood C.S., Pappolla M.A., Bowen R.L., Perry G., and Smith M.A. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim. Biophys. Acta 1762 (2006) 447-452
8. Chakravarti S., Collins W.P., Forecast J.D., Newton J.R., Oram D.H., and Studd J.W. Hormonal profiles after the menopause. Br. Med. J. 2 (1976) 784-787
9. Couzinet B., and Schaison G. The control of gonadotrophin secretion by ovarian steroids. Hum. Reprod. 8 Suppl. 2 (1993) 97-101
10. Fowler C.D., Johnson F., and Wang Z. Estrogen regulation of cell proliferation and distribution of estrogen receptor-alpha in the brains of adult female prairie and meadow voles. J. Comp. Neurol. 489 (2005) 166-179
11. Genazzani A.R., Gastaldi M., Bidzinska B., Mercuri N., Genazzani A.D., Nappi R.E., Segre A., and Petraglia F. The brain as a target organ of gonadal steroids. Psychoneuroendocrinology 17 (1992) 385-390
12. Gould E., Tanapat P., Rydel T., and Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiatry 48 (2000) 715-720
13. Gurland B., Katz S., Lantigua R.A., and Wilder D.E. Proceedings of the 1991 International Symposium on Data on Aging. Cognitive function and the elderly. Vital Health Stat. 5 (1993) 21-26
14. Henderson V.W., Paganini-Hill A., Emanuel C.K., Dunn M.E., and Buckwalter J.G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51 (1994) 896-900
15. Jorm A.F., Korten A.E., and Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76 (1987) 465-479
16. Joseph J.A., Denisova N.A., Arendash G., Gordon M., Diamond D., Shukitt-Hale B., and Morgan D. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr. Neurosci. 6 (2003) 153-162
17. Katzman R. Alzheimer's disease as an age-dependent disorder. Ciba Found Symp. 134 (1988) 69-85
18. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., and Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48 (1997) 1517-1521
19. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26 (2002) 91-104
20. Larson E.B., Kukull W.A., and Katzman R.L. Cognitive impairment: dementia and Alzheimer's disease. Annu. Rev. Public Health 13 (1992) 431-449
21. Lei Z.M., Rao C.V., Kornyei J.L., Licht P., and Hiatt E.S. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132 (1993) 2262-2270
22. Lei Z.M., Mishra S., Zou W., Xu B., Foltz M., Li X., and Rao C.V. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol. Endocrinol. 15 (2001) 184-200
23. Lei Z.M., and Rao C.V. Neural actions of luteinizing hormone and human chorionic gonadotropin. Semin. Reprod. Med. 19 (2001) 103-109
24. Lukacs H., Hiatt E.S., Lei Z.M., and Rao C.V. Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm. Behav. 29 (1995) 42-58
25. Manly J.J., Merchant C.A., Jacobs D.M., Small S.A., Bell K., Ferin M., and Mayeux R. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54 (2000) 833-837
26. Mann R.J., Keri R.A., and Nilson J.H. Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestation pregnancy failure. Endocrinology 140 (1999) 2592-2601
27. Mann R.J., Keri R.A., and Nilson J.H. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology. Recent Prog. Horm. Res. 58 (2003) 343-375
28. McDowd J.M., and Craik F.I. Effects of aging and task difficulty on divided attention performance. J. Exp. Psychol. Hum. Percept. Perform. 14 (1988) 267-280
29. McGonigal G., Thomas B., McQuade C., Starr J.M., MacLennan W.J., and Whalley L.J. Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88. BMJ 306 (1993) 680-683
30. Mulnard R.A. Estrogen as a treatment for alzheimer disease. JAMA 284 (2000) 307-308
31. Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., and Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283 (2000) 1007-1015
32. Neaves W.B., Johnson L., Porter J.C., Parker Jr. C.R., and Petty C.S. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J. Clin. Endocrinol. Metab. 59 (1984) 756-763
33. Ohta R.J., Walsh D.A., and Krauss I.K. Spatial perspective-taking ability in young and elderly adults. Exp. Aging Res. 7 (1981) 45-63
34. Ormerod B.K., Lee T.T., and Galea L.A. Estradiol enhances neurogenesis in the dentate gyri of adult male meadow voles by increasing the survival of young granule neurons. Neuroscience 128 (2004) 645-654
35. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., and Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2663-2672
36. Risma K.A., Clay C.M., Nett T.M., Wagner T., Yun J., and Nilson J.H. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1322-1326
37. Risma K.A., Hirshfield A.N., and Nilson J.H. Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology 138 (1997) 3540-3547
38. Rocca W.A., Hofman A., Brayne C., Breteler M.M., Clarke M., Copeland J.R., Dartigues J.F., Engedal K., Hagnell O., Heeren T.J., et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann. Neurol. 30 (1991) 381-390
39. Schally A., and Nagy A. Targeted cytotoxic analogs of luteinizing hormone-releasing hormone: a reply. Eur. J. Endocrinol. 144 (2001) 559
40. Sharps M.J. Spatial memory in young and elderly adults: category structure of stimulus sets. Psychol. Aging 6 (1991) 309-312
41. Sherwin B.B. Estrogen and memory in women: how can we reconcile the findings?. Horm. Behav. 47 (2005) 371-375
42. Short R.A., Bowen R.L., O'Brien P.C., and Graff-Radford N.R. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin. Proc. 76 (2001) 906-909
43. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones III B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., and Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
44. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996) 429-432
45. Webber K.M., Casadesus G., Marlatt M.W., Perry G., Hamlin C.R., Atwood C.S., Bowen R.L., and Smith M.A. Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis. Ann. N.Y. Acad. Sci. 1052 (2005) 201-209
46. Weber R.J., Brown L.T., and Weldon J.K. Cognitive maps of environmental knowledge and preference in nursing home patients. Exp. Aging Res. 4 (1978) 157-174
47. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., and Breitner J.C. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 (2002) 2123-2129